David Dalmau
Universidade Federal do Rio Grande do Norte(BR)International Olive Council(ES)University Hospital Mútua de Terrassa(ES)Mútua Terrassa(ES)
Publications by Year
Research Areas
HIV/AIDS Research and Interventions, HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV-related health complications and treatments, Pneumocystis jirovecii pneumonia detection and treatment
Most-Cited Works
- → Autoantibodies against type I IFNs in patients with life-threatening COVID-19(2020)2,815 cited
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → Human genetic and immunological determinants of critical COVID-19 pneumonia(2022)384 cited
- → Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients with Human Immunodeficiency Virus Infection(2003)293 cited
- → The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies(2022)183 cited
- → Epigenome-wide association study of COVID-19 severity with respiratory failure(2021)158 cited